Immune response elicited by SARS-CoV-2 vaccines in infliximab and vedolizumab-treated patients with IBD - News-Medical.Net
A recent study evaluates the immune responses elicited by COVID-19 vaccines in infliximab- or vedolizumab-treated IBD patients.
The coronavirus disease 2019 (COVID-19) pandemic has resulted in devastating effects worldwide and currently, vaccines are the only safeguard. Scientists and pharmaceutical companies have successfull… [+11114 chars]
Read More
Other Stories in Health
- Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
- Where and why men die younger: global data breaks it down
- 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
- Strawberry Lemon Cream Crepes {Grain-Free Options Included}
- What predicts belief in the afterlife? A massive global study has answers
- Getting active in midlife may boost brain resilience to Alzheimer’s
- May 2025 Cooking Challenge
- May 2025 Cooking Challenge
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
.png)
